Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain

BACKGROUND: Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamycin-resist...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Clin Microbiol Antimicrob
Главные авторы: Sowajassatakul, Angkanang, Prammananan, Therdsak, Chaiprasert, Angkana, Phunpruch, Saranya
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047124/
https://ncbi.nlm.nih.gov/pubmed/30008266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0285-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы